Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion type Assertion NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_head.
- NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion description "[For example, systemic delivery of recombinant ES to rat insulin promoter 1 (Rip1)T-antigen 2 (Tag2)-transgenic mice, a mouse model of pancreatic beta-cell carcinogenesis, has repressed tumor angiogenesis efficiently and with it, tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_provenance.
- NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion evidence source_evidence_literature NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_provenance.
- NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion SIO_000772 16793908 NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_provenance.
- NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion wasDerivedFrom befree-2016 NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_provenance.
- NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_assertion wasGeneratedBy ECO_0000203 NP556171.RAPAIVatS2s_dkdRPJ0Yv_F9gS4gYJBsD0eCtEu2cuOK0130_provenance.